|
SNAPC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.648100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.428460E-02 |
| Normal-vs-Stage2 |
6.882600E-01 |
| Normal-vs-Stage3 |
5.879200E-01 |
| Normal-vs-Stage4 |
1.442760E-01 |
| Stage1-vs-Stage2 |
1.619200E-01 |
| Stage1-vs-Stage3 |
5.768000E-02 |
| Stage1-vs-Stage4 |
7.832600E-01 |
| Stage2-vs-Stage3 |
9.716400E-01 |
| Stage2-vs-Stage4 |
3.741400E-01 |
| Stage3-vs-Stage4 |
2.754800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.834300E-02 |
| Normal-vs-AfricanAmerican |
1.801180E-03 |
| Normal-vs-Asian |
1.979410E-01 |
| Caucasian-vs-AfricanAmerican |
3.916200E-02 |
| Caucasian-vs-Asian |
9.436800E-01 |
| AfricanAmerican-vs-Asian |
7.853600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.986580E-01 |
| Normal-vs-Female |
3.623900E-02 |
| Male-vs-Female |
4.887400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.060700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.333600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.196200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.060600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.382400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.622400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.338000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.727600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.253430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.529830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.639200E-01 |
| Classical-VS-Follicular |
1.490570E-01 |
| Classical-VS-Other |
9.801800E-01 |
| Classical-VS-Normal |
1.489850E-02 |
| Tall-VS-Follicular |
1.884020E-01 |
| Tall-VS-Other |
9.122600E-01 |
| Tall-VS-Normal |
4.866000E-02 |
| Follicular-VS-Other |
6.323000E-01 |
| Follicular-VS-Normal |
5.211600E-01 |
| Other-VS-Normal |
3.124000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.032400E-01 |
| Normal-vs-N1 |
2.390800E-01 |
| N0-vs-N1 |
3.631400E-01 |
|
|
